<DOC>
	<DOCNO>NCT00970970</DOCNO>
	<brief_summary>Von Hippel Lindau disease ( VHLD ) inherit syndrome characterized vascular malformation , kidney cancer , adrenal gland pancreas tumor . The VHL protein functional different disease associate lesion result production high amount vascular endothelial growth factor ( VEGF ) . Currently clinical , radiographic molecular marker predict natural history give lesion . With 89Zr-bevacizumab positron emission tomography ( PET ) scanning , VEGF visualize quantify . The investigator hypothesize 89Zr-bevacizumab PET image useful tool predict behaviour disease associate lesion patient VHLD . Adult patient VHLD routine magnetic resonance imaging ( MRI ) scan central nervous system ( CNS ) abdomen undergo 89Zr-bevacizumab PET scan . MRI repeat within 12 month .</brief_summary>
	<brief_title>Visualizing Vascular Endothelial Growth Factor ( VEGF ) Producing Lesions Von Hippel-Lindau Disease</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma , Renal Cell</mesh_term>
	<mesh_term>Neuroendocrine Tumors</mesh_term>
	<mesh_term>Carcinoid Tumor</mesh_term>
	<mesh_term>Pheochromocytoma</mesh_term>
	<mesh_term>Adenoma , Islet Cell</mesh_term>
	<mesh_term>Von Hippel-Lindau Disease</mesh_term>
	<mesh_term>Hemangioblastoma</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<mesh_term>Endothelial Growth Factors</mesh_term>
	<mesh_term>Mitogens</mesh_term>
	<criteria>clinically genetically proven VHLD least 1 measurable , VHL associate lesion CNS routine MRI CNS ≤ 6 week inclusion routine CT MRI upper abdomen ≤ 3 month inclusion plan ≤ 3 month 89Zrbevacizumab PET scan age ≥ 18 year write informed consent must give accord good clinical practice ( GCP ) , local regulation pregnancy psychological , familial , sociological geographical condition potentially hamper compliance study protocol , condition discuss patient registration trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>Vascular endothelial growth factor</keyword>
	<keyword>von Hippel Lindau disease</keyword>
	<keyword>molecular imaging</keyword>
	<keyword>biomarker</keyword>
</DOC>